{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:54:34Z","timestamp":1765961674929,"version":"3.40.5"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study explores the role of steroid administration in identifying distressed or even mentally disordered cancer patients (so\u2010called case finding). Charts of 12\u2009298 cancer patients (4499 treated with prednisone equivalents) were analysed descriptively. A subset of 10\u2009945 was further explored via latent class analysis (LCA). LCA avoids confounding by indication because it subgroups patients without prior preconceptions based on homogeneous expression of traits (i.e. the variables examined). LCA identified four subgroups: two subgroups with high dosages of prednisone equivalent (\u226580\u2009mg\/day on average over all treatment days) and two with low dosages. The two subgroups with high average dosages had an increased likelihood of psychotropic drug administration, but only one was more likely to require 1:1 observation. In one subgroup, low dosages of prednisone equivlents correlated with a slightly increased probability for a psychiatric assessment and psychotropic drug administration. The subgroup least likely to receive steroid treatment was also the least likely to receive a psychiatric assessment and psychotropic drug administration. Descriptive statistics on age, sex, cumulative inpatient treatment, type of cancer, stage of cancer at first diagnosis, mental disorders, severe mental disorders and psychotropic drug administration (antidepressants, antipsychotics, benzodiazepines, anticonvulsants\/mood stabilizers, opioids) are provided for patients receiving no, less and more than 80\u2009mg of prednisone equivalent.<\/jats:p>","DOI":"10.1111\/bcpt.13853","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T02:09:50Z","timestamp":1678154990000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Steriod\u2010associated psychiatric burden in cancer patients"],"prefix":"10.1111","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-5532","authenticated-orcid":false,"given":"Moritz Philipp","family":"G\u00fcnther","sequence":"first","affiliation":[{"name":"Department of Consultation\u2010Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich University of Zurich Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0531-9104","authenticated-orcid":false,"given":"Philip Maximilian","family":"Riemann","sequence":"additional","affiliation":[{"name":"Department of Consultation\u2010Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich University of Zurich Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-5129","authenticated-orcid":false,"given":"Roland","family":"von K\u00e4nel","sequence":"additional","affiliation":[{"name":"Department of Consultation\u2010Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich University of Zurich Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-8355","authenticated-orcid":false,"given":"Sebastian","family":"Euler","sequence":"additional","affiliation":[{"name":"Department of Consultation\u2010Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich University of Zurich Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5252-3976","authenticated-orcid":false,"given":"Jan Ben","family":"Schulze","sequence":"additional","affiliation":[{"name":"Department of Consultation\u2010Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich University of Zurich Zurich Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102407\u20108\u201084"},{"key":"e_1_2_7_3_1","first-page":"225","article-title":"Corticosteroids in advanced cancer","volume":"15","author":"Wooldridge JE","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon\u20102017\u20100306"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1972135part1694"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11071009"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357908909041378"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022\u20103999(03)00514\u20102"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5743"},{"key":"e_1_2_7_10_1","unstructured":"OnkologieL.S3\u2010leitlinie supportive therapie.https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Supportivtherapie\/LL_Supportiv_Langversion_1.1.pdf"},{"key":"e_1_2_7_11_1","unstructured":"optimal_resources_for_cancer_care_2020_standards.https:\/\/www.facs.org\/-\/media\/files\/quality-programs\/cancer\/coc\/optimal_resources_for_cancer_care_2020_standards.ashx"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2013.01.012"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2021.08.004"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2022.100849"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibaa115"},{"volume-title":"ICD\u201010: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision","year":"2016","author":"World Health Organization (WHO)","key":"e_1_2_7_16_1"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1037\/tps0000176"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.2307\/2283868"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2517-6161.1977.tb01600.x","article-title":"Maximun likelihood estimation from incomplete data","volume":"39","author":"Dempster AP","year":"1977","journal-title":"J Royal Stat Soc (B)"},{"volume-title":"Variable\u2010Specific Entropy Contribution","year":"2018","author":"Asparouhov T MB","key":"e_1_2_7_20_1"},{"key":"e_1_2_7_21_1","article-title":"Comparing approaches for testing the number of components in a finite mixture model","volume":"9","author":"Soromenho G","year":"1994","journal-title":"Computat Stat"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/%28SICI%291097%2D0258%2819971015%2916:19%3C2157::AID%2DSIM653%3E3.0.CO%3B2%2DX"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v042.i10"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097\u20100142(19881015)62:1"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.2960020404"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.13853","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcpt.13853","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.13853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T21:57:34Z","timestamp":1729029454000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcpt.13853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1111\/bcpt.13853"],"URL":"https:\/\/doi.org\/10.1111\/bcpt.13853","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"type":"print","value":"1742-7835"},{"type":"electronic","value":"1742-7843"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"assertion":[{"value":"2023-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}